tirzepatide novo nordisk FDA Grants a New Indication for Obesity Management Novo Nordisk A/S is suing

This accidental discovery in reptile venom sparked decades of pharmaceutical development leading to modern medications like semaglutide, now available through PlexusDx

They fear that if individuals regain the weight post-GLP-1, not only will they have spent significant resources in vain, but the weight may return in a less-healthy manner, potentially leaving individuals in a worse clinical state than before

However, in patients who develop chronic conditions, this oxidative fire is never successfully extinguished, leading to sustained collateral damage to the hosts own tissues

[CrossRef] [PubMed] [Google Scholar] Insulin in the brain: There and back again

Conclusion When you look at GLP-1 and GIP weight loss treatments, it helps to remember that the right medication is the one you can access, tolerate, and stay consistent with over time